ClearPath: A Viable Alternative for Select Patients

ClearPath: A Viable Alternative for Select Patients

Feeling like you can’t get a full breath through your nose—especially on one side—can affect sleep, exercise, and everyday comfort. Many people describe it as “always congested,” even when they’re not sick. For a large subset of patients, a deviated septum (the wall that divides the nostrils) is a major contributor.

Traditional septoplasty can be very effective, but it’s not the only approach being explored today. ClearPath is a device designed to help select patients improve nasal airflow with a less invasive technique. Below is a patient-friendly overview of what the ClearPath nasal balloon is, who it may be for, what recovery can look like, and what early studies suggest so far. (1,2,3)

What is ClearPath (and what problem is it designed to solve)?

A quick definition (in plain language)

ClearPath Nasal Balloon (CNB) is a single-use, force-directed balloon catheter system designed to increase space inside the nose and help correct certain septal deviations—without cutting, lifting tissue flaps, sutures, or nasal packing in many cases. (1,2)

It received FDA 510(k) clearance in 2019 (21 CFR 874.4420, product code QGK). (2) In practical terms, it’s intended to offer a “septoplasty-like” improvement for the right anatomy while aiming to reduce how much tissue is disturbed along the way.

The symptoms that often bring patients in

- Ongoing stuffiness or “blocked nose” feeling

- Breathing better through one nostril than the other

- Sleep disruption (snoring, poor sleep quality, waking up congested)

- Facial pressure or headache symptoms

- Reduced quality of life from chronic nasal symptoms (often tracked with symptom questionnaires such as SNOT-22 in research settings) (3)

A concrete example: someone might be able to breathe “okay” at rest, but notice they can’t tolerate exercise as well—or they wake up repeatedly because one side of the nose feels sealed shut.

Bottom line: ClearPath is designed to reposition the nasal divider for select deviation types, aiming to improve airflow with less tissue disruption.

Why “select patients” is the key phrase

ClearPath is not meant to replace every septoplasty. The goal is to offer a minimally invasive septoplasty alternative for patients whose anatomy is suitable for this specific approach. (1,2) One helpful way to think about it: some deviations can be improved by repositioning, while others require more structural reconstruction. ClearPath is designed for the former.

Who may be a good candidate

In clinical materials, ClearPath is generally positioned for: (1,2)

- Patients age 17+

- Persistent nasal obstruction that does not improve enough with appropriate medications (like sprays or allergy management) (1)

- Mild-to-moderate deviation patterns that may be amenable to balloon-assisted septoplasty

A qualified ENT evaluation is essential because symptoms alone don’t reliably predict whether the septum can be improved with this method. Two people can report the same “10/10 congestion,” yet have very different anatomy on exam.

Best-candidate guidance: best candidates for balloon septoplasty with ClearPath (https://www.clearpathnasal.com/blog/best-candidates-for-balloon-septoplasty-with-clearpath)

Who is typically NOT a candidate

ClearPath may not be appropriate when a deviation is complex enough to require traditional structural techniques. Examples commonly listed include: (1,2)

- Severe caudal or dorsal deformities that need reconstruction

- Significant bony spurs that may require more extensive tissue elevation

- Congenital craniofacial or “gross anatomical abnormalities”

- Patients under 17

Key idea: candidacy hinges on anatomy—some septal deviations can be repositioned, while others need reconstruction.

How the ClearPath nasal balloon works (step-by-step, no graphic required)

The core concept: controlled, directional repositioning

The ClearPath nasal balloon approach uses a controlled, directional balloon expansion to help mobilize and reposition targeted areas of the septum—rather than removing pieces of cartilage or bone. The “force-directed” design is intended to apply pressure in a way that helps realign specific deviations while protecting surrounding tissues. (4)

In patient terms: think of it like gently nudging a slightly bowed divider back toward center, instead of cutting out parts of it. The goal is more room for airflow, achieved through repositioning rather than excision. (1,4)

What makes it different from traditional septoplasty

Compared with many conventional septoplasty techniques, ClearPath is described as aiming to avoid:

- Mucosal flap elevation

- Cartilage excision

- Sutures

- Nasal packing (in many cases) (1,2)

That difference matters to many patients because flap elevation, sutures, and packing are often the parts people associate with “more downtime” or a heavier post-procedure feeling. Every nose is different, and some patients still need additional procedures or traditional approaches.

Step-by-step explainer: how the ClearPath nasal balloon works (step-by-step) (https://www.clearpathnasal.com/blog/how-the-clearpath-nasal-balloon-works-a-step-by-step-guide)

In essence: ClearPath seeks to realign select deviations through controlled balloon force, aiming for less tissue disruption than traditional techniques.

ClearPath vs. traditional septoplasty: what patients usually want to know

When patients compare options, the biggest concerns are usually time, anesthesia, downtime, and comfort. Many people aren’t just asking “Will it work?”—they’re also asking “What will the week after look like?”

Procedure time and anesthesia

ClearPath is often presented as a relatively brief in-office procedure—commonly described around 10–15 minutes—typically with local anesthesia. (1,3) Traditional septoplasty often takes longer and may be done with deeper anesthesia depending on the case and setting.

Recovery timeline

Many ClearPath materials describe returning to routine activities within about 24–48 hours, though recovery varies by individual and by whether other nasal procedures are performed at the same visit. (1) Traditional septoplasty recovery can be longer, and patients may need more time before they feel fully “back to normal.” Your clinician’s post-procedure instructions should always guide activity level, nose care, and symptom expectations.

Packing and discomfort

One reason some patients explore the ClearPath nasal balloon option is the possibility of avoiding nasal packing when appropriate. (1,2) Comfort still varies, but less invasive techniques are often pursued specifically to reduce downtime and the sensation of congestion from swelling and healing.

Comparison guide: ClearPath vs. traditional septoplasty (https://www.clearpathnasal.com/blog/clearpath-vs-traditional-septoplasty-recovery-safety-results)

Takeaway: patients often consider ClearPath for the potential of a short in-office visit, local anesthesia, and a quicker return to routine—when their anatomy fits.

What does the evidence say so far?

Research is still early, but there is a growing published foundation for balloon-assisted septoplasty using this approach. The best available data so far helps answer two core questions: Does anatomy improve? and Do patients feel better?

Results from a 107-case retrospective study (what improved)

A retrospective study of 107 consecutive cases reported no major complications such as septal perforation, synechiae (scar bands), CSF leak, orbital injury, or conversion to another surgical approach. (3) This kind of case series is helpful but does not carry the same strength as a randomized, controlled trial.

Imaging outcomes (CT-measured realignment)

In a subgroup that had pre- and post-treatment CT imaging (n=23), the study reported: (3)

- Average 45% improvement at the point of maximal deviation

- Average 22% improvement at the nasolacrimal duct level

- 78% achieved at least 30% improvement

- No patients worsened in that subgroup

Symptom outcomes (SNOT-22)

Among patients who completed symptom surveys at about one month (n=43), average SNOT-22 scores improved from 58.7 to 44.8—about a 23.8% reduction. The largest improvements were reported in congestion, facial pressure/headache, and sleep-related symptoms. (3) Manufacturer materials may cite larger symptom reductions (for example, 66% at one month), which is higher than the peer-reviewed figure above. (1,3)

A balanced take: what we still don’t know

It’s important to interpret early outcomes appropriately. Much of the published data is retrospective, often single-center, and typically uncontrolled. Independent review has noted the need for longer-term, controlled studies to better define durability and ideal patient selection. (4)

In brief: early results are encouraging for appropriately selected patients, but higher-level, longer-term studies are still needed.

Safety, risks, and what “minimally invasive” really means

“Minimally invasive” does not mean “no risk.” It usually means the technique is designed to reduce tissue disruption and shorten recovery—while still requiring good patient selection and careful technique.

What complications were NOT seen in the published series

In the 107-case retrospective report, there were no major complications reported (including no septal perforation or significant scar banding). (3) That’s encouraging—especially because septal perforation is one of the complications patients often worry about.

Potential side effects to discuss with your ENT

- Temporary tenderness, pressure, or swelling

- Minor bleeding

- Persistent obstruction if the deviation is more complex than it initially appeared

- The possibility of needing additional treatment if symptom relief is incomplete

When traditional septoplasty may still be the better choice

Traditional septoplasty may remain the better fit when a patient needs more extensive structural correction—especially for more severe caudal deviations, major bony spurs, or complex anatomy where repositioning alone may not be enough. (1,2,4)

Practical view: “less invasive” can mean less tissue disturbance, but it still requires the right anatomy and realistic expectations.

Cost and access considerations (what patients should ask)

Device cost vs. total procedure cost

ClearPath materials list a $499 price per catheter (device only). (1,2) That is not the same as the total cost of care, which can also include clinic/facility fees, clinician fees, medications, and follow-up. Insurance coverage can vary widely—so it’s smart to ask for a written estimate and coverage check if possible.

Questions for your consult

- Am I a candidate for the ClearPath nasal balloon approach?

- Is my deviation mild/moderate—or more severe/caudal?

- Will I need any additional procedures at the same visit?

- What results are realistic for my anatomy and goals?

- What is the backup plan if my breathing doesn’t improve enough?

FAQ hub: ClearPath FAQs (https://www.clearpathnasal.com/faqs)

Perspective: the device price is one piece—coverage, setting, and any additional procedures determine the full cost.

How to know if you should explore ClearPath

A simple checklist (patient-friendly)

- Are 17+

- Have ongoing nasal obstruction despite appropriate medical treatment

- Have suspected or confirmed mild-to-moderate septal deviation

- Do not have a known major structural deformity requiring reconstruction

- Are willing to have a formal ENT evaluation (and additional assessment if needed)

Next step

If you’re considering the ClearPath Nasal Balloon (CNB), the best next step is to ask your local ENT whether ClearPath could be an appropriate alternative to traditional septoplasty for your specific anatomy and goals.

Next step: an in-person exam with an ENT is the only way to confirm whether your septum is well-suited to this approach.

Conclusion: ClearPath can be a strong option—for the right patient

ClearPath is a device-based, balloon-assisted septoplasty approach intended to improve nasal airflow with less tissue disruption. For select patients, the potential benefits—short procedure time, local anesthesia, and a faster return to routine activities—are appealing. (1,3) Early published outcomes show encouraging realignment and symptom improvements with a strong safety signal in a retrospective series. (3) At the same time, “select patients” is the key phrase: anatomy matters, and long-term, controlled data is still developing. (4)

If you’re deciding between approaches, individualized evaluation and shared decision-making with a qualified ENT is the most reliable guide.

References

1. ClearPath Nasal Balloon System – For Physicians (2025): https://www.clearpathnasal.com/for-physicians

2. Intuit Medical Products. ClearPath Nasal Balloon System Product Playbook (Jan 2025): https://cdn.prod.website-files.com/677c332b780dde6482217dbf/67d2f0e3114831f3dd6189e1_ClearPath%2BPlaybook-compressed.pdf

3. Dillard J, et al. Outcomes of force-directed balloon-assisted endoscopic septoplasty. Rhinology Online (2025/2026): https://www.rhinologyonline.org/Rhinology_online_issues/manuscript_2530.pdf

4. Brenner MJ, et al. New Medical Device and Therapeutic Approvals in Otolaryngology. OTO Open (2021): https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/2473974X211057035

This article is for educational purposes only and is not medical advice. Please consult a qualified healthcare provider for diagnosis and treatment.